Pinnacle Financial Partners (Georgia)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
2,037
-7
-0.3% -$1.51K ﹤0.01% 842
2026
Q1
$410K Sell
2,044
-52
-2% -$10.8K ﹤0.01% 862
2025
Q4
$433K Buy
+2,096
New +$419K ﹤0.01% 828

Other funds holding FBT

Pinnacle Financial Partners (Georgia)'s FBT Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.34% in Q2 2026, selling an estimated $1.51K and leaving 2,037 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #842.

Pinnacle Financial Partners (Georgia) first reported a position in FBT in Q4 2025 and has held it in 3 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 2,037 shares of First Trust NYSE Arca Biotechnology Index Fund worth $505K as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 7 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.51K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #842 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 3 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.